References
- Nathan D. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676–85
- Alexiou P, Pegklidou K, Chatzopoulou M, et al. Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 2009;16:734–52
- Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38
- Nishikawa T, Edelstein D, Du X, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787–90
- Yamagishi SI, Edelstein D, Du XI, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001;50:1491–4
- Kikkawa R, Hatanaka I, Yasuda H, et al. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia 1983;24:290–2
- Ao S, Shingu Y, Kikuchi C, et al. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metab Clin Exp 1991;40:77–87
- Van Zandt MC, Jones ML, Gunn DE, et al. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J Med Chem 2005;48:3141–52
- La Motta C, Sartini S, Salerno S, et al. Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model. J Med Chem 2008;51:3182–93
- Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007;9:343–53
- Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009;16:763–74
- Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci 2007;64:35–43
- Stefek M, Snirc V, Djoubissie P, et al. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: synthesis, activity, partitioning, and molecular modeling. Bioorg Med Chem 2008;16:4908–20
- Li S, Zhang D, Yang L, Li Y. Study on the total synthesis of velbanamine: chemoselective dioxygenation of alkenes with PIFA via a stop-and-flow strategy. Beilstein J Org Chem 2013;9:983–90
- Przybylski P, Huczynski A, Pyta K. Biological properties of schiff bases and azo derivatives of phenols. Curr Org Chem 2009;13:124–48
- Isemura M, Timmermann BN. Plant polyphenols and health benefits. Curr Pharm Design 2013;19:6051–2
- Chen X, Yang Y, Ma B, et al. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridyl-thiadiazine scaffold. Eur J Med Chem 2011;46:1536–44
- Liu Y, Yi-Lin L, Karin M, et al. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. J Med Chem 2003;46:1580–8
- Li M, Han X, Yu B. Facile synthesis of flavonoid 7-O-glycosides. J Org Chem 2003;68:6842–5
- Max VD, Christine ML, Dong VM. Rhodium-phosphoramidite catalyzed alkene hydroacylation: mechanism and octaketide natural product synthesis. J Am Chem Soc 2012;134:15022–32